Investor Mark Carnegie believes cardiovascular medical device company EBR Systems, which hits the big board on Wednesday, will be the next Cochlear and change lives around the world.
Silicon Valley-based EBR was founded in 2003 and developed the WiSE Cardiac resynchronisation therapy system, which uses proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
